| scholarly article | Q13442814 |
| P2093 | author name string | Gill MJ | |
| Gingues S | |||
| P2860 | cites work | Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators | Q29547281 |
| AIDS-associated cancer in developing nations. | Q30342705 | ||
| Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma | Q33765321 | ||
| Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults | Q33925343 | ||
| Clinical presentations and standard therapy of AIDS-associated Kaposi's sarcoma | Q35174141 | ||
| Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy | Q35213923 | ||
| Starting highly active antiretroviral therapy: why, when and response to HAART. | Q35784402 | ||
| Pathogenesis of HIV-associated non-Hodgkin lymphoma | Q35848169 | ||
| Advances in the pathobiology and treatment of Kaposi sarcoma | Q35864760 | ||
| Anogenital neoplasia in AIDS. | Q35864769 | ||
| Kaposi's sarcoma: an update | Q35873462 | ||
| Antitumour effects of antiretroviral therapy | Q35934144 | ||
| AIDS-related cancer in the era of highly active antiretroviral therapy (HAART): a model of the interplay of the immune system, virus, and cancer. "On the offensive--the Trojan Horse is being destroyed"--Part B: Malignant lymphoma | Q35973889 | ||
| A recurrent pattern of chromosomal aberrations and immunophenotypic appearance defines anal squamous cell carcinomas | Q36431440 | ||
| Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-Infected patients receiving highly active an | Q39682736 | ||
| Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003. | Q40433154 | ||
| Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma | Q40579145 | ||
| Improved survival in HIV-related Hodgkin's lymphoma since the introduction of highly active antiretroviral therapy | Q44246134 | ||
| Rates of disease progression among human immunodeficiency virus-infected persons initiating multiple-drug rescue therapy | Q44407123 | ||
| HIV protease inhibitors as new treatment options for Kaposi's sarcoma | Q44577471 | ||
| Outcome in patients with non-hodgkin lymphoma and with or without human immunodeficiency virus infection | Q45703817 | ||
| Functional restoration of human immunodeficiency virus and Epstein-Barr virus-specific CD8(+) T cells during highly active antiretroviral therapy is associated with an increase in CD4(+) T cells | Q45733134 | ||
| Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma | Q46473122 | ||
| Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma. | Q47367466 | ||
| Cancer incidence in New York State acquired immunodeficiency syndrome patients | Q48798413 | ||
| Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy | Q56342211 | ||
| Trends in AIDS-Defining and Non--AIDS-Defining Malignancies among HIV-Infected Patients: 1989-2002 | Q58975060 | ||
| P433 | issue | 6 | |
| P921 | main subject | anti-retroviral agent | Q50430310 |
| P304 | page(s) | 369-377 | |
| P577 | publication date | 2006-09-01 | |
| P1433 | published in | HIV Medicine | Q15756376 |
| P1476 | title | The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta | |
| P478 | volume | 7 |
| Q34039651 | AIDS-associated Kaposi's sarcoma is linked to advanced disease and high mortality in a primary care HIV programme in South Africa |
| Q33585427 | Effect of HAART on incident cancer and noncancer AIDS events among male HIV seroconverters |
| Q36668229 | Hepatocellular cancer in HIV-infected individuals: tomorrow's problem? |
| Q34963626 | Higher levels of neutralizing antibodies against KSHV in KS patients compared to asymptomatic individuals from Zambia |
| Q36162341 | Impact of antiretroviral therapy on the incidence of Kaposi's sarcoma in resource-rich and resource-limited settings |
| Q33446895 | KS-Detect - Validation of Solar Thermal PCR for the Diagnosis of Kaposi's Sarcoma Using Pseudo-Biopsy Samples |
| Q41391348 | Spectrum of malignancies among HIV-infected patients in South India |
| Q90299113 | The Effect of MSM and CD4+ Count on the Development of Cancer AIDS (AIDS-defining Cancer) and Non-cancer AIDS in the HAART Era |
| Q57832203 | The oncology impact of highly active antiretroviral therapy |
| Q27481175 | Viruses and human cancer |
Search more.